What Doctors Don't Tell YouNew US guidelines meant to take the guesswork out of diagnosing ‘high’ cholesterol in patients could lead to a dramatic, and inappropriate, increase in the number of people receiving lipid-lowering drug therapy, according to a recent report.
New US guidelines meant to take the guesswork out of diagnosing ‘high’ cholesterol in patients could lead to a dramatic, and inappropriate, increase in the number of people receiving lipid-lowering drug therapy, according to a recent report.
